Historical review from 2026-09-05. Current price and availability are unconfirmed; check the original marketplace.
Insect Bite ID generates $2.8K/mo revenue with an extraordinary 99.98% profit margin and a highly attractive 2.21x annual profit multiple. Platform verification and clean data increase confidence. However, the business is young with no disclosed age or customer retention metrics, and the claimed near-100% margin warrants confirmation of cost structure and whether all operational expenses are accounted for. The AI-native product model is reproducible, but the verified traction and sub-2.5x valuation create a compelling acquisition case if customer stickiness and churn can be confirmed.
The core AI bite-identification engine can be built as an MVP using off-the-shelf vision APIs (Google Cloud Vision, AWS Rekognition, or OpenAI's vision models), a basic backend (Node/Python), and managed hosting for $4–12K over 6 weeks with an AI subscription. However, the acquisition captures verified monthly profit of $2.8K, a paying customer base with demonstrated product-market validation, and an operational track record. The sub-2.5x multiple and 99.98% margin provide strong cash-return potential, provided churn is low and customer acquisition cost is sustainable. The score reflects 70% weight on proven traction and unit economics, 20% on acquisition risk (young age and margin verification), and only 10% on software reproducibility. The verified revenue and exceptional multiple outweigh build-it-yourself logic unless customer retention proves weak.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Snap a photo to identify insect bites in seconds with AI. Get confidence scores, bite care advice, and track bites over time for extra peace of mind.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.